Skip to main content

Providing independent clinical excellence since 2005

The SCVC Blog

Cardiovascular care news and articles from our expert team

Statins, Absolute Benefit, and the Problem of Residual Risk

When people think about cholesterol, they often imagine it as something floating in the blood, disconnected from body fat. In reality, the type and location of body fat — particularly visceral fat (VAT) — profoundly influence how the liver packages and clears cholesterol. Raised VAT doesn’t just sit silently around the organs; it acts like an endocrine organ, sending chemical distress signals that shift lipid metabolism in an atherogenic direction.

Who Can You Trust? The Rise of Anti-Statin Narratives and the Crisis of Trust in Modern Medicine

One of the greatest challenges in the online world is investigator bias. Any “expert” with a strong conviction — whether pro- or anti-statin — can easily find studies that appear to confirm their view. The internet is full of such cherry-picked data. When presented with confident authority, this can sound utterly convincing to a lay audience. The reality is that true medical understanding does not come from one paper, one YouTube video, or one self-proclaimed authority.

Examples of CT VAT scans and normal ranges for VATI

At SCVC we use low dose CT to measure visceral adipose tissue (VAT). With a radiation dose of 1mSv - equivalent to 1/4 of the dose used in a mammogram. The test determines what proportion of an expanded waistline is visceral (metabolically dangerous) versus subcutaneous (metabolically benign) fat. When combined with other anthropometrics such as weight, height, waist we use AI to calculate a metabolically healthy target waist and weight to aim for. A example of a repeat scan after 3 months of GLP-1 mimetic is also shown.